Ultragenyx Pharmaceutical (RARE) Insider Trading & Ownership $52.43 -1.36 (-2.53%) (As of 10/7/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ultragenyx Pharmaceutical (NASDAQ:RARE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$7.22 M Get RARE Insider Trade Alerts Want to know when executives and insiders are buying or selling Ultragenyx Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RARE Insider Buying and Selling by Quarter Ad Stansberry ResearchAmerica's Crime Problem Now Leaking to U.S. Stock MarketHow bad must it be if the NYPD, the largest police department in America, needs help from the military? But according to one wealthy and reclusive market analyst, who has accurately predicted many of our country's biggest catastrophic events in recent years, this isn't just about police or crime...Click here to access his latest analysis. Ultragenyx Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/3/2024Emil D KakkisCEOSell20,000$55.85$1,117,000.00 9/3/2024Theodore Alan HuizengaCAOSell91$56.19$5,113.29 8/6/2024Emil D KakkisCEOSell20,000$50.17$1,003,400.00 7/2/2024Corazon (Corsee) D SandersDirectorSell584$40.98$23,932.32 6/12/2024Karah Herdman ParschauerEVPSell9,806$45.00$441,270.00 6/10/2024Corazon (Corsee) D SandersDirectorSell1,737$41.10$71,390.70 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/18/2024Eric CrombezEVPSell142$44.10$6,262.20 3/11/2024Thomas Richard KassbergEVPSell11,509$49.93$574,644.37 3/7/2024Matthew K FustDirectorSell12,195$50.88$620,481.60 3/1/2024John Richard PinionInsiderSell4,173$53.76$224,340.48 3/1/2024Karah Herdman ParschauerEVPSell3,756$53.76$201,922.56 3/1/2024Theodore Alan HuizengaCAOSell341$53.76$18,332.16 10/23/2023Thomas Richard KassbergEVPSell39,878$32.78$1,307,200.84 10/19/2023Emil D KakkisCEOSell47,853$33.52$1,604,032.56 (Data available from 1/1/2013 forward) RARE Insider Trading Activity - Frequently Asked Questions Who is on Ultragenyx Pharmaceutical's Insider Roster? The list of insiders at Ultragenyx Pharmaceutical includes Camille L Bedrosian, Corazon (Corsee) D Sanders, Dennis Karl Huang, Emil D Kakkis, Eric Crombez, Erik Harris, John Richard Pinion, Karah Herdman Parschauer, Mardi Dier, Matthew K Fust, Theodore Alan Huizenga, and Thomas Richard Kassberg. Learn more on insiders at RARE. What percentage of Ultragenyx Pharmaceutical stock is owned by insiders? 5.80% of Ultragenyx Pharmaceutical stock is owned by insiders. Learn more on RARE's insider holdings. Which Ultragenyx Pharmaceutical insiders have been selling company stock? The following insiders have sold RARE shares in the last 24 months: Camille L Bedrosian ($175,615.25), Corazon (Corsee) D Sanders ($199,377.87), Dennis Karl Huang ($17,757.85), Emil D Kakkis ($3,724,432.56), Eric Crombez ($6,262.20), Erik Harris ($242,461.00), John Richard Pinion ($324,940.48), Karah Herdman Parschauer ($840,202.56), Mardi Dier ($198,579.12), Matthew K Fust ($620,481.60), Theodore Alan Huizenga ($264,746.71), and Thomas Richard Kassberg ($1,881,845.21). How much insider selling is happening at Ultragenyx Pharmaceutical? Insiders have sold a total of 202,016 Ultragenyx Pharmaceutical shares in the last 24 months for a total of $8,496,702.41 sold. More Insider Trading Tools from MarketBeat Related Companies: PRGO Insider Transactions IONS Insider Transactions JAZZ Insider Transactions ACAD Insider Transactions ARWR Insider Transactions UTHR Insider Transactions DNA Insider Transactions SMMT Insider Transactions GMAB Insider Transactions VTRS Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are Buying This page (NASDAQ:RARE) was last updated on 10/7/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredStrikes and Economic Unrest: Are You Prepared for What’s Coming?The rapid advancement of artificial intelligence and automation is reshaping industries and posing threats to ...InvestorPlace | SponsoredNotice: Major payout due November 19th - are you on the list?On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's p...Behind the Markets | SponsoredU.S. Stock Market Now on Verge of Collapse"Wheels Are Falling Off" The U.S. Stock Market Today, analyst Dan Ferris is back issuing a new warning. He ...Stansberry Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultragenyx Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ultragenyx Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.